tech
AI executive action stalled by White House infighting
Early talk of federal safety reviews of new AI models has cooled off.
TL;DR
- Internal disagreements within the Trump administration are holding up the development of federal AI regulation.
- The upcoming China summit is influencing the timing of any potential AI policy announcements.
- Administration officials have expressed conflicting views on safety reviews for AI models, such as the idea of an 'FDA for AI'.
- Concerns exist about the cybersecurity capabilities of Chinese AI models and the need to harden U.S. systems.
- The industry is seeking clarity and guidance on AI testing, cybersecurity, and government contracting.
- There is an internal debate about whether advanced AI testing should fall under civilian or national security branches of the government.
- A website for frontier AI testing from a Department of Commerce division was taken down shortly after it was publicized.